The efficacy and safety of anlotinib combined with chemotherapy in treatment of advanced soft tissue sarcoma
Crossref DOI link: https://doi.org/10.1007/s12672-024-01492-1
Published Online: 2024-10-29
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ni, Ying
Dong, Yabing
Jiang, Aijun
Zhang, Qun
Wang, Zhantong
Liang, Hui
Zhang, Wei
Text and Data Mining valid from 2024-10-29
Version of Record valid from 2024-10-29
Article History
Received: 9 July 2024
Accepted: 22 October 2024
First Online: 29 October 2024
Declarations
:
: The authors declare no competing interests.